Published in J Acquir Immune Defic Syndr on September 01, 1993
Human microsporidial infections. Clin Microbiol Rev (1994) 4.66
Zoonotic potential of the microsporidia. Clin Microbiol Rev (2005) 2.76
Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev (2002) 2.67
Clinical significance of enteric protozoa in the immunosuppressed human population. Clin Microbiol Rev (2009) 2.34
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut (2011) 2.21
Epidemiology of Enterocytozoon bieneusi Infection in Humans. J Parasitol Res (2012) 1.41
Detection of Cryptosporidium parvum DNA in human feces by nested PCR. J Clin Microbiol (1996) 1.29
Unapparent microsporidial infection among immunocompetent humans in the Czech Republic. J Clin Microbiol (2010) 1.21
Study of opportunistic intestinal parasitic infections in human immunodeficiency virus/acquired immunodeficiency syndrome patients. J Glob Infect Dis (2013) 0.83
Etiology and evaluation of diarrhea in AIDS:a global perspective at the millennium. World J Gastroenterol (2000) 0.81
Prevalence and molecular characterization of human and bovine Cryptosporidium isolates in Thailand. Parasitol Res (2008) 0.79
Infections by Intestinal Coccidia and Giardia duodenalis. Clin Lab Med (2015) 0.78
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23
The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology (2001) 3.02
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology (2004) 2.97
Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet (1981) 2.80
Acquired itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother (2001) 2.69
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (1990) 2.61
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet (2000) 2.58
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis (1999) 2.20
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med (1995) 2.06
Molecular characterization of Cryptosporidium isolates obtained from humans in France. J Clin Microbiol (2001) 2.05
Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. Clin Infect Dis (1996) 1.98
Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat (2001) 1.89
Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis (2006) 1.77
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology (1997) 1.74
Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis (1994) 1.72
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J Antimicrob Chemother (1999) 1.58
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun (1993) 1.48
The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J (1985) 1.45
Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection. Lancet (1988) 1.43
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother (2006) 1.40
In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus. J Med Microbiol (1999) 1.39
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med (1981) 1.34
Improved diagnosis of strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 1.34
Identification of Encephalitozoon intestinalis in travelers with chronic diarrhea by specific PCR amplification. J Clin Microbiol (1998) 1.32
Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet (1971) 1.30
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment. Hepatology (1999) 1.29
Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation (1999) 1.27
Clinical consequences of hepatitis C virus infection. Rev Med Virol (2003) 1.27
Intravenous vitamin complexes used in sporting activities and transmission of HCV in Brazil. Am J Gastroenterol (1999) 1.26
Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol (1976) 1.25
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis (1994) 1.20
Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol (1997) 1.20
ParaSight-F rapid manual diagnostic test of Plasmodium falciparum infection. Bull World Health Organ (1995) 1.19
Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases. Antimicrob Agents Chemother (1984) 1.18
Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol (2000) 1.17
Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother (2000) 1.17
Comparison of HIV detection by virus isolation in lymphocyte cultures and molecular amplification of HIV DNA and RNA by PCR in offspring of seropositive mothers. J Acquir Immune Defic Syndr (1991) 1.16
Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest (1997) 1.15
Genetic polymorphism of Aspergillus fumigatus in clinical samples from patients with invasive aspergillosis: investigation using multiple typing methods. J Clin Microbiol (2001) 1.15
Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med (1994) 1.15
In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants. Antimicrob Agents Chemother (2007) 1.14
Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis. Lancet (1979) 1.14
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepat (2003) 1.12
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut (2003) 1.11
Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO. J Med Vet Mycol (1997) 1.10
Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology (1999) 1.09
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine. J Viral Hepat (2006) 1.09
Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Med Interne (Paris) (1992) 1.07
Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine. Antiviral Res (1984) 1.07
Nosocomial Pneumocystis jirovecii infections. Parasite (2008) 1.06
Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks. Antimicrob Agents Chemother (1990) 1.06
Letter: Detection of e antigen by immunofluorescence in cytoplasm of hepatocytes of HBsAg carriers. Lancet (1976) 1.04
Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men. J Infect Dis (1985) 1.04
Toxoplasmosis in pregnancy. Lancet (1994) 1.03
Multicentric epidemiological study of Aspergillus fumigatus isolates by multilocus enzyme electrophoresis. J Clin Microbiol (1996) 1.02
Plasma viraemia as a marker of viral replication in HIV-infected individuals. AIDS (1991) 1.02
Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol (1993) 1.02
Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides. Virology (1993) 1.01
Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01
Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol (1996) 1.00
[Presence of Leishmania major Yakimoff and Schokhor, 1914 in Mali. Enzymatic identification of a strain of human origin]. Ann Parasitol Hum Comp (1985) 0.99
Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication. Hepatology (1990) 0.99
[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99
Multicentric evaluation of a new real-time PCR assay for quantification of Cryptosporidium spp. and identification of Cryptosporidium parvum and Cryptosporidium hominis. J Clin Microbiol (2013) 0.99
Trichosporon inkin endocarditis: short-term evolution and clinical report. Clin Infect Dis (1996) 0.98
Severe peritonitis due to Balantidium coli acquired in France. Eur J Clin Microbiol Infect Dis (2004) 0.98
Maintenance of woodchuck hepatitis virus activity in woodchuck hepatocyte primary culture. J Gen Virol (1987) 0.98
Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy. J Clin Virol (2004) 0.97
Molecular typing of Aspergillus fumigatus strains by sequence-specific DNA primer (SSDP) analysis. FEMS Immunol Med Microbiol (1997) 0.96
A case of disseminated Scedosporium apiospermum infection after bone marrow transplantation. Mykosen (1987) 0.95
Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis (1994) 0.95
Woodchuck hepatitis virus infection: serologic and histopathologic course and outcome. Eur J Clin Microbiol (1985) 0.95
Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing. Hepatology (1989) 0.95
Evidence for shared epitopes between cardiolipin and Pneumocystis carinii. J Infect Dis (1989) 0.95
Sarcoidosis possibly predisposing to disseminated histoplasmosis. Thorax (1988) 0.95
[Hepatitis B antigen (HB Ag and Australia antigen). Clinical value of its detection by solid phase radioimmunoassay (R.I.A.)]. Nouv Presse Med (1973) 0.95
Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Cancer Res (1994) 0.95
Testing for HCV-RNA in commercial intravenous immunoglobulins. Lancet (1993) 0.94